Éva Szökő Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

4/2017

Association between metabolically healthy central obesity in women and levels of soluble receptor for advanced glycation end products, soluble vascular adhesion protein-1, and the activity of semicarbazide-sensitive amine oxidase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Éva Szökő Research Topics

Disease

5	Insulin Resistance 01/2023 - 04/2015
4	Neuralgia (Stump Neuralgia) 08/2023 - 10/2021
3	Pain (Aches) 04/2023 - 03/2021
3	Obesity 05/2022 - 04/2015
3	Inflammation (Inflammations) 07/2021 - 04/2015
2	Hyperalgesia 08/2023 - 04/2023
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 04/2017
2	Neuroblastoma 10/2020 - 08/2020
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 11/2018
2	Schizophrenia (Dementia Praecox) 05/2019 - 01/2018
1	Prediabetic State (Prediabetes) 01/2023
1	Body Weight (Weight, Body) 05/2022
1	Chronic Pain 10/2021
1	Type 2 Diabetes Mellitus (MODY) 07/2021
1	Mood Disorders (Mood Disorder) 05/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2017
1	Abdominal Obesity 04/2017
1	Corneal Injuries 06/2013
1	Corneal Neovascularization 06/2013

Drug/Important Bio-Agent (IBA)

4	Analgesics (Analgesic Drugs)IBA 08/2023 - 10/2021
4	Insulin (Novolin)FDA Link 07/2021 - 04/2015
3	Sucrose (Saccharose)IBA 01/2023 - 04/2015
3	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 04/2015
2	TolperisoneIBA 08/2023 - 08/2022
2	Opioid Analgesics (Opioids)IBA 04/2023 - 10/2021
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 07/2021
2	AdipokinesIBA 05/2022 - 04/2017
2	LeptinIBA 05/2022 - 04/2017
2	Triglycerides (Triacylglycerol)IBA 07/2021 - 04/2015
2	Streptozocin (Streptozotocin)FDA Link 06/2021 - 01/2020
2	Serine (L-Serine)FDA Link 08/2020 - 01/2018
2	Monoamine Oxidase (MAO)IBA 01/2020 - 11/2018
2	Antidepressive Agents (Antidepressants)IBA 01/2020 - 11/2018
2	Dopamine (Intropin)FDA LinkGeneric 05/2019 - 11/2018
2	Amine Oxidase (Copper-Containing)IBA 04/2017 - 06/2013
2	Proteins (Proteins, Gene)FDA Link 04/2015 - 06/2013
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 08/2023
1	Pregabalin (Lyrica)FDA Link 08/2023
1	Losartan (Cozaar)FDA LinkGeneric 04/2023
1	Telmisartan (Micardis)FDA Link 04/2023
1	Glutamic Acid (Glutamate)FDA Link 04/2023
1	Morphine (MS Contin)FDA LinkGeneric 04/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	Liraglutide FDA Link 01/2023
1	Ion Channels (Ion Channel)IBA 08/2022
1	CytokinesIBA 05/2022
1	AdiponectinIBA 05/2022
1	KisspeptinsIBA 05/2022
1	LigandsIBA 10/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2021
1	Opioid Receptors (Opioid Receptor)IBA 10/2021
1	AngiotensinsIBA 10/2021
1	Uric Acid (Urate)IBA 07/2021
1	AminesIBA 07/2021
1	Exenatide (Byetta)FDA Link 06/2021
1	Glycogen Synthase Kinase 3IBA 06/2021
1	TeaIBA 10/2020
1	Protective AgentsIBA 01/2020
1	Levodopa (L Dopa)FDA LinkGeneric 01/2020
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 01/2020
1	Antipsychotic Agents (Antipsychotics)IBA 05/2019
1	Selegiline (E250)FDA LinkGeneric 11/2018
1	Neuroprotective AgentsIBA 11/2018
1	ElementsIBA 11/2018
1	rasagiline (Azilect)FDA Link 11/2018
1	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 01/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018
1	Receptor for Advanced Glycation End ProductsIBA 04/2017
1	Biomarkers (Surrogate Marker)IBA 04/2017
1	LipidsIBA 04/2017
1	C-Reactive ProteinIBA 04/2017
1	FructoseIBA 04/2015
1	Thiobarbituric Acid Reactive SubstancesIBA 04/2015
1	Drinking WaterIBA 04/2015
1	AntioxidantsIBA 04/2015
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 06/2013
1	N'-(2-phenylallyl)hydrazineIBA 06/2013
1	human AOC3 proteinIBA 06/2013

Therapy/Procedure

3	Therapeutics 08/2023 - 06/2013
3	Ligation 08/2023 - 03/2021
1	Analgesia 08/2023
1	Oral Administration 04/2023